Page last updated: 2024-12-11
gr 122222x
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
GR 122222X: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5748227 |
| MeSH ID | M0234727 |
Synonyms (10)
| Synonym |
|---|
| unii-nf9u2lvf79 |
| gr122222x |
| l-alanyl-(3r)-3-hydroxy-l-prolyl-l-seryl-s-((2-carboxy-4,6-dihydroxy-3-methylphenyl)methyl)-l-cysteinyl-l-alanine (4-3)-lactone |
| nf9u2lvf79 , |
| 161161-54-2 |
| l-alanine, l-alanyl-(3r)-3-hydroxy-l-prolyl-l-seryl-s-((2-carboxy-4,6-dihydroxy-3-methylphenyl)methyl)-l-cysteinyl-, (4-3)-lactone |
| gr 122222x |
| [(2s)-2-[[(2s)-2-aminopropanoyl]-[(2r)-2-[[(2s)-3-hydroxy-2-[[(2s,3r)-3-hydroxypyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-sulfanylidenepropanoyl]amino]propanoyl] 3,5-dihydroxy-2-methyl-6-(sulfanylmethyl)benzoate |
| DTXSID50167071 |
| (s)-2-((s)-2-amino-n-((r)-2-((s)-3-hydroxy-2-((2s,3r)-3-hydroxypyrrolidine-2-carboxamido)propanamido)-3-thioxopropanoyl)propanamido)propanoic 3,5-dihydroxy-2-(mercaptomethyl)-6-methylbenzoic anhydride |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.60) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||